Piramal Pharma Limited (BOM:543635)
India
· Delayed Price · Currency is INR 164.30
-4.45 (-2.64%)
At close: Apr 28, 2026
Piramal Pharma Market Cap
Piramal Pharma has a market cap or net worth of 218.39 billion as of April 28, 2026. Its market cap has decreased by -25.90% in one year.
Market Cap
218.39B
Enterprise Value
259.46B
Revenue
88.71B
Ranking
n/a
PE Ratio
n/a
Stock Price
164.30
Market Cap Chart
Since October 19, 2022, Piramal Pharma's market cap has decreased from 226.73B to 218.39B, a decrease of -3.68%. That is a compound annual growth rate of -1.06%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 218.39B | -4.49% |
| Dec 31, 2025 | 228.67B | -35.22% |
| Dec 31, 2024 | 352.98B | 92.16% |
| Dec 29, 2023 | 183.69B | 34.26% |
| Dec 30, 2022 | 136.81B | -39.66% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca Pharma India | 211.45B |
| Granules India | 174.71B |
| Rubicon Research | 157.95B |
| Jubilant Pharmova | 149.04B |
| J. B. Chemicals & Pharmaceuticals | 328.12B |
| Caplin Point Laboratories | 131.65B |
| GlaxoSmithKline Pharmaceuticals | 414.21B |
| CORONA Remedies | 103.13B |